Track topics on Twitter Track topics that are important to you
Scientists at The Scripps Research Institute have developed a small molecule-based RNA editing tool that can selectively delete RNA targets associated with diseases such as cancer. Offering a potential alternative to CRISPR-Cas9 -based tools that edit DNA, the new technology, developed by Matthew D. Disney, Ph.D., attaches an RNA-targeting drug-like molecule to an RNA-degrading enzyme.Because the technology uses small molecules rather than proteins, it could also feasibly be packaged into a convenient, oral pill. Initial tests demonstrated that a ribonuclease-targeting chimera (RIBOTAC) designed against a breast cancer microRNA oncogene caused the death of malignant cells, without harming normal cells. "I believe this is just the tip of the iceberg of how this approach will ultimately be applied," says Disney. “Since it is now known that RNA is a key driver in nearly every disease, optimization of this approach that turns a cell's natural defenses toward destroying disease-causing RNAs ...
Original Article: Small-Molecule RNA-Targeting Technology Kills Cancer CellsNEXT ARTICLE
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...